{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:18:25Z","timestamp":1780363105125,"version":"3.54.1"},"reference-count":41,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"abstract":"<jats:p>Cyclosporine A (CsA), a well-known immunosuppressive drug, has been prescribed after organ transplantation and in a variety of disorders with an immunological origin. Nephrotoxicity is one of the most frequently stated problems associated with CsA, and therefore the treatment with CsA remains a big challenge. This study sets out to assess the ameliorative influences of Candesartan Cilexetil (CC) on oxidative stress and the nephrotoxic effect of CsA in a rat model. Twenty-four Wister Albino rats, 7\u20138-week-old, weighing 150\u2013250g, were randomly categorized into three groups (eight animals in each group). These groups were the (1) CsA-treated group, (2) vehicle-treated group, and (3) CC-treated group. Bodyweights were assessed at the start and end of experiments. Renal function test and levels of glutathione peroxidase 1 catalase -CAT (Gpx1), catalase (CAT), superoxide dismutase (SOD), interleukin -2 (IL-2), and malondialdehyde (MDA) were investigated in renal tissues. Histological changes in kidneys were also evaluated. Data showed that levels of urea and creatinine in serum and levels of IL-2 and MDA in renal tissues were elevated in the CsA-treated group, with severe histological changes compared with the control group. Furthermore, tissue levels of Gpx1, CAT, and SOD were significantly decreased in CsA-treated in comparison with the control group. Treatment with CC for the rats subjected to CSA resulted in a marked reduction in levels of serum urea and creatinine and tissue levels of IL-2 and MDA. Levels of Gpx1, CAT, and SOD in renal tissues were greater in the CC-treatment group compared with the CsA-treated group. CC treatment reduced the deterioration of renal morphology compared with CsA treatment. The findings of this study suggest that CC could prevent CSA-induced nephrotoxicity through its anti-inflammatory and antioxidant influences. Considerably more work needs to be done to determine the mechanistic insight behind the ameliorative effect of CC.<\/jats:p>","DOI":"10.25122\/jml-2021-0227","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:48:10Z","timestamp":1683524890000},"page":"1553-1562","source":"Crossref","is-referenced-by-count":4,"title":["Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model"],"prefix":"10.25122","volume":"15","author":[{"given":"Fadhaa Abdulameer","family":"Ghafil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah Abdulridha Abdul","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Al-Diwanyah Health Directorate, Al-Diwanyah, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heider","family":"Qassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najah Rayish","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"* Corresponding Author: Najah Rayish Hadi, Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq. E-mail: drnajahhadi@yahoo.com","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10755","published-online":{"date-parts":[[2022,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Burdmann BA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity, Semin. Nephrol. 2003, 23(5): 465\u2013476, doi: 10.1016\/S0270-9295(03)00090-1.","DOI":"10.1016\/S0270-9295(03)00090-1"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Lee J. Use of antioxidants to prevent cyclosporine a toxicity. Toxicol. Res. 2010; 26(3): 163-170, doi: 10.5487\/TR.2010.26.3.163.","DOI":"10.5487\/TR.2010.26.3.163"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Hagar HH. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol. Lett. 2004; 151(2):335-343, doi: 10.1016\/j.toxlet.2004.03.002.","DOI":"10.1016\/j.toxlet.2004.03.002"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Yang CW, Ahn HJ, Kim WY, Li C, et al. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation. 2003; 75(3): 309-315, doi: 10.1097\/01. TP.0000045034.48833.51.","DOI":"10.1097\/01.TP.0000045034.48833.51"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Li C, Lim SW, Sun BK, Yang CW. Chronic cyclosporine nephrotoxicity: new insights and preventive strategies. Yonsei Med. J. 2004; 45(6): 1004-1016, doi: 10.3349\/ymj.2004.45.6.1004.","DOI":"10.3349\/ymj.2004.45.6.1004"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Li C, Yang CW, Park CW, Ahn HJ, et al. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int. 2003; 63(2): 454-463, doi: https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00751.x.","DOI":"10.1046\/j.1523-1755.2003.00751.x"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin. J. Am. Soc. Nephrol. 2009; 4(2): 481\u2013508, doi: https:\/\/doi.org\/10.2215\/ CJN.04800908.","DOI":"10.2215\/CJN.04800908"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Kurtz A, Bruna DR, K\u00fchn K. Cyclosporine A enhances renin secretion and production in isolated juxtaglomerular cells. Kidney Int. 1988; 33(5): 947-953, doi: https:\/\/doi.org\/10.1038\/ki.1988.92.","DOI":"10.1038\/ki.1988.92"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Blankenstein KI, Borschewski A, Labes R, Paliege A, et al. Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms. Am. J. Physiol. Physiol. 2017; 312(3): F489-F501, doi: https:\/\/doi.org\/10.1152\/ajprenal.00575.2016.","DOI":"10.1152\/ajprenal.00575.2016"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Cid TP, Garc\u0131a JRC, Alvarez FC, De Arriba G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology. 2003; 189(1\u20132): 99-111, doi: https:\/\/doi.org\/10.1016\/s0300-483x(03)00156-2.","DOI":"10.1016\/S0300-483X(03)00156-2"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Hussein SA, Ragab OA, El-Eshmawy MA. Renoprotective effect of dietary fish oil on cyclosporine a: induced nephrotoxicity in rats. Asian J. Biochem. 2014; 9(2): 71-85, doi: https:\/\/dx.doi.org\/10.3923\/ajb.2014.71.85.","DOI":"10.3923\/ajb.2014.71.85"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Gleiter CH, J\u00e4gle C, Gresser U, Candesartan MK. Cardiovasc. Drug Rev.2004; 22(4): 263-284, doi: https:\/\/doi.org\/10.1111\/j.1527-3466.2004. tb00146.x.","DOI":"10.1111\/j.1527-3466.2004.tb00146.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Akishita M, Horiuchi M, Yamada H, Zhang L, et al. Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol. Genomics. 2000; 2(1): 13-20, doi: https:\/\/doi.org\/10.1152\/ physiolgenomics.2000.2.1.13.","DOI":"10.1152\/physiolgenomics.2000.2.1.13"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Ruiz-Ortega M, Lorenzo O, Rup\u00e9rez M, K\u00f6nig S, et al. Angiotensin II activates nuclear transcription factor \u03baB through AT1 and AT2 in vascular smooth muscle cells: molecular mechanisms. Circ. Res. 2000; 86(12): 1266-1272, doi: https:\/\/doi.org\/10.1161\/01.res.86.12.1266.","DOI":"10.1161\/01.RES.86.12.1266"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994; 74(6): 1141-1148, doi: https:\/\/doi. org\/10.1161\/01.res.74.6.1141.","DOI":"10.1161\/01.RES.74.6.1141"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Nickenig G, Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation. 2002; 105(3): 393-396, doi: https:\/\/doi.org\/10.1161\/hc0302.102618.","DOI":"10.1161\/hc0302.102618"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Kalaitzidis R, Bakris GL. Effects of angiotensin II receptor blockers on diabetic nephropathy. Journal of Hypertension. 2009; 27(SUPPL. 5. LWW): S15-S21, doi: 10.1097\/01.hjh.0000357904.71080.7d.","DOI":"10.1097\/01.hjh.0000357904.71080.7d"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Khan BV, Navalkar S, Khan QA, Rahman ST, Parthasarathy S. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease. J. Am. Coll. Cardiol. 2001; 38(6): 1662-1667, doi: https:\/\/doi.org\/10.1016\/s0735-1097(01)01615-1.","DOI":"10.1016\/S0735-1097(01)01615-1"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Ogawa S, Kobori H, Ohashi N, Urushihara M, et al. Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy. Biomark. Insights. 2009; 4(4): 97-102, doi: 10.4137\/BMI.S2733.","DOI":"10.4137\/BMI.S2733"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Sato-Horiguchi C, Ogawa D, Wada J, Tachibana H, et al. Telmisartan Attenuates Diabetic Nephropathy by Suppressing Oxidative Stress in db\/db Mice. Nephron Exp. Nephrol. 2012; 121(3\u20134): e97-e108, doi: 10.1159\/000343102.","DOI":"10.1159\/000343102"},{"key":"ref21","unstructured":"21. Garcia-Cohen EC, Marin J, Diez-Picazo LD, Baena AB, Salaices M. Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2. J Pharmacol Exp Ther. 2000; 293(1):75-81.2022; https:\/\/pubmed.ncbi.nlm. nih.gov\/10734155\/"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Buffoli B, Pech\u00e1nov\u00e1 O, Kojsov\u00e1 S, Andriantsitohaina R et al. Provinol Prevents CsA-induced Nephrotoxicity by Reducing Reactive Oxygen Species, iNOS, and NF-kB Expression. J. Histochem. Cytochem. 2005; 53(12): 1459, doi: 10.1369\/JHC.5A6623.2005.","DOI":"10.1369\/jhc.5A6623.2005"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Mazali FC, Johnson RJ, Mazzali M. Use of uric acid-lowering agents limits experimental cyclosporine nephropathy. Nephron Exp. Nephrol. 2012; 120(1): e12-e19, doi: https:\/\/doi.org\/10.1159%2F000330274.","DOI":"10.1159\/000330274"},{"key":"ref24","unstructured":"24. Emam HT, Madboly AG, Shoman AA, Hussein NI. The Possible Protective Role of Candesartan on Cyclosporine Induced Nephrotoxicity in Rats. Med. J. Cairo Univ. 2013; 81(2)."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Aktoz T, Aydogdu N, Alagol B, Yalcin O et al. The protective effects of melatonin and vitamin E against renal ischemia-reperfusion injury in rats. Ren. Fail. 2007; 29(5): 535-542, doi: https:\/\/doi.org\/10.1080\/08860220701391738.","DOI":"10.1080\/08860220701391738"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Liu HB, Meng QH, Huang C, Wang HB, Liu XW. Nephroprotective effects of polydatin against ischemia\/reperfusion injury: a role for the PI3K\/Akt signal pathway. Oxid. Med. Cell. Longev. 2015, doi: https:\/\/doi. org\/10.1155\/2015\/362158.","DOI":"10.1155\/2015\/362158"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Rossoni G, Gomaraschi M, Berti F, Sirtori CR, et al. L. Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia\/reperfusion injury. J. Pharmacol. Exp. Ther. 2004; 308(1): 79-84, doi: https:\/\/doi. org\/10.1124\/jpet.103.057141.","DOI":"10.1124\/jpet.103.057141"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Chiao H, Kohda Y, McLeroy P, Craig L, et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 1997; 99(6): 1165-1172, doi: https:\/\/doi.org\/10.1172%2FJCI119272.","DOI":"10.1172\/JCI119272"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Hadj Abdallah N, Baulies A, Bouhlel A, Bejaoui M, et al. Zinc mitigates renal ischemia-reperfusion injury in rats by modulating oxidative stress, endoplasmic reticulum stress, and autophagy. J. Cell. Physiol. 2018; 233(11): 8677-8690, doi: https:\/\/doi.org\/10.1002\/jcp.26747.","DOI":"10.1002\/jcp.26747"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Fu ZJ, Wang ZY, Xu L, Chen XH, et al. HIF-1\u03b1-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia\/reperfusion injury. Redox Biol. 2020; 36(101671), https:\/\/doi.org\/10.1016\/j.redox.2020.101671.","DOI":"10.1016\/j.redox.2020.101671"},{"key":"ref31","unstructured":"31. Abdulridha S, Kadhim A, Ghafil FA, Majeed S, Hadi NR. Nephroprotective effects of Curcumin against cyclosporine A-induced Nephrotoxicity in rat model. Wiadomo\u015bci Lekarskie. 2021; LXXIV (12). DOI: 10.36740\/ WLek202112103"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Hagar HH, El Etter E, Arafa M. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin. Exp. Pharmacol. Physiol. 2006; 33(3): 189-196, doi: https:\/\/doi.org\/10.1111\/j.1440-1681.2006.04345.x.","DOI":"10.1111\/j.1440-1681.2006.04345.x"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Heibashy M, El-Nahrawy W, Zaki N. Cyclosporine-Induced Oxidative Stress and renal Dysfunction in Rat kidneys: A Possible Ameliorated Effect by Curcumin as an Antioxidant. Bull. Egypt. Soc. Physiol. Sci. 2009; 29(2): 179-194, doi: https:\/\/dx.doi.org\/10.21608\/besps.2009.36716.","DOI":"10.21608\/besps.2009.36716"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Hussein SA, Ragab OA, El-Eshmawy MA. Protective effect of dietary fish oil on cyclosporine a-induced nephrotoxicity in rats. Benha Vet Med J. 2013; 25(2): 218-231, doi: https:\/\/dx.doi.org\/10.3923\/ajb.2014.71.85.","DOI":"10.3923\/ajb.2014.71.85"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Kasap B, Soylu A, Kuralay F, Sarioglu S, et al. Protective effect of Epo on oxidative renal injury in rats with cyclosporine nephrotoxicity. Pediatr. Nephrol. 2008; 23(11): 1991-1999, https:\/\/doi.org\/10.1007\/s00467-008-0903-1.","DOI":"10.1007\/s00467-008-0903-1"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Tirkey N, Kaur G, Vij G, Chopra K. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol. 2005; 5(1): 1-10, doi: https:\/\/doi. org\/10.1186\/1471-2210-5-15.","DOI":"10.1186\/1471-2210-5-15"},{"key":"ref37","unstructured":"37. Garcia-Cohen EC, Marin J, Diez-Picazo LD, Baena AB et al. Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoform. J. Pharmacol. Exp. Ther. 2000; 293(1): 75-81."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Sereno J, Rodrigues-Santos P, Vala H, Rocha-Pereira P, et al. Transition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model. Int. J. Mol. Sci. 2014; 15(5): 8979-8997, https:\/\/doi.org\/10.3390\/ ijms15058979.","DOI":"10.3390\/ijms15058979"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Amudha G, Josephine A, Varalakshmi P. Role of lipoic acid in reducing the oxidative stress induced by cyclosporine A. Clin. Chim. Acta. 2006; 372(1\u20132): 134-139, doi: https:\/\/doi.org\/10.1016\/j.cca.2006.03.036.","DOI":"10.1016\/j.cca.2006.03.036"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. Mohamadin AM, El-Beshbishy HA, El-Mahdy MA. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol. Res. 2005; 51(1): 51-57, https:\/\/doi.org\/10.1016\/j.phrs.2004.04.007.","DOI":"10.1016\/j.phrs.2004.04.007"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Inselmann G, Barth A, Engemann R, Heidemann HTH. Cyclosporin-Ainduced lipid peroxidation in human liver microsomes and its influence on cytochrome P-450. Eur. J. Clin. Invest. 1991; 21(5): 461-465, https:\/\/doi. org\/10.1111\/j.1365-2362.1991.tb01395.x.","DOI":"10.1111\/j.1365-2362.1991.tb01395.x"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/16.-jml-2021-0227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:48:21Z","timestamp":1683524901000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/wp-content\/uploads\/16.-jml-2021-0227.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["JMedLife-15-1553"],"URL":"https:\/\/doi.org\/10.25122\/jml-2021-0227","relation":{},"ISSN":["1844-122X","1844-3117"],"issn-type":[{"value":"1844-122X","type":"print"},{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}